Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: HEPARIN FLUSH SYRINGE; HEPARIN, VASCULAR ACCESS FLUSH
  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

HEPARIN FLUSH SYRINGE; HEPARIN, VASCULAR ACCESS FLUSH Back to Search Results
Device Problem Device Markings/Labelling Problem (2911)
Patient Problem Insufficient Information (4580)
Event Description
The 5 units/ 5 ml heparin flush syringe ((b)(4)) and 2 units/ 2 ml heparin flush syringe ((b)(4)) are identical.They are even in the same size syringe (6 ml) with overfill.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HEPARIN FLUSH SYRINGE
Type of Device
HEPARIN, VASCULAR ACCESS FLUSH
MDR Report Key12844262
MDR Text Key281206388
Report NumberMW5105473
Device Sequence Number1
Product Code NZW
Combination Product (y/n)Y
Number of Events Reported1
Summary Report (Y/N)N
Report Source Voluntary
Reporter Occupation Unknown
Type of Report Initial
Report Date 03/24/2021
2 Devices were Involved in the Event: 1   2  
1 Patient was Involved in the Event
Date FDA Received11/18/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? No
Patient Sequence Number1
-
-